We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+27.72%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$542M
AUM Growth
+$95.6M
Cap. Flow
-$17.9M
Cap. Flow %
-3.3%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TBIO
Translate Bio, Inc. Common Stock
TBIO
+$17.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 82.49%
2 Healthcare 11.66%
3 Communication Services 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
1
DraftKings
DKNG
$11.4B
$447M 82.49%
7,284,008
– –
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$30.9M 5.7%
1,872,115
-784,402
-30% -$17.9M
ROKU icon
3
Roku
ROKU
$21.1B
$18.8M 3.47%
57,707
– –
BCYC
4
Bicycle Therapeutics
BCYC
$270M
$18.3M 3.38%
612,696
– –
SNAP icon
5
Snap
SNAP
$7.32B
$12.8M 2.37%
245,559
– –
FSTX
6
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$6.23M 1.15%
574,996
– –
LRMR icon
7
Larimar Therapeutics
LRMR
$416M
$4.27M 0.79%
292,184
– –
VRDN icon
8
Viridian Therapeutics
VRDN
$2.13B
$3.5M 0.65%
209,505
– –

Similar funds

RCWM
Red Crane Wealth Management San Francisco, California $122M AUM 14.77% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
SO
Sierra Ocean Ripon, California $122M AUM 16.19% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Atlas Venture Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Atlas Venture Advisors held 8 positions worth $542M, up 21% from $446M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Advisors withdrew a net $17.9M in Q1 2021, reducing 1 holding. Its largest reduction was Translate Bio, Inc. Common Stock, cutting an estimated $17.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 82% of assets, up from 76% a quarter earlier, followed by Healthcare and Communication Services.

  • Atlas Venture Advisors's biggest Q1 2021 reduction was Translate Bio, Inc. Common Stock, cutting an estimated $17.9M.
  • Atlas Venture Advisors's ten largest holdings make up 100% of its $542M portfolio in Q1 2021.
  • Atlas Venture Advisors opened 0 new positions and closed 0 in Q1 2021.
  • Atlas Venture Advisors's portfolio value rose 21% quarter-over-quarter to $542M.

Based on Atlas Venture Advisors's 13F filing for Q1 2021, filed 14 May 2021.